Primary Glaucoma Treatment Trial in Kenya and South Africa - SLT vs. Medication
Status:
Terminated
Trial end date:
2019-01-01
Target enrollment:
Participant gender:
Summary
Multi-centre randomised controlled trial of selective laser trabeculoplasty compared with
prostaglandin analogue therapy as primary treatment for high tension open angle glaucoma.
Participating centres are:
Institute of Ophthalmology, UCL, London, UK McCord Hospital, Durban, South Africa Innovation
Eye Centre, Kisii, Kenya
Phase:
N/A
Details
Lead Sponsor:
University College, London
Collaborators:
Kisii Eye Hospital Kisii Kenya University of KwaZulu